Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Impact of an educational program on efficacy and adherence with a twice-daily Lamivudine/Zidovudine/Abicavir regimen in underrepresented HIV-infected patients

Article Abstract:

The effect of an HIV educational program on efficacy and adherence with a simple, compact, twice-daily triple nucleoside regimen containing a lamivudine/zidovudine combination tablet plus abacivir is evaluated. The intervention is limited to patient empowerment and improving knowledge about HIV and its treatment.

Author: Thompson, Melanie A., Tolson, Jerry M., Scott, Robert C., Rawlings, Keith M., Farthing, Charles F., Brown, Lawrence S., Racine, Joseph, Crawford, Karen H., Goodwin, Diane S., Williams, Venessa C., Shaefer, Mark S.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2003
Care and treatment, HIV patients, AIDS education

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Impact of zidovudine-based triple combination therapy on an AIDS Drug Assistance Program

Article Abstract:

Triple drug therapy compared to therapy with a single drug might be cost-effective if the treatment lowers the risk of opportunistic infections. This was the conclusion of researchers who estimated the economic impact of triple therapy on New York's AIDS Drug Assistance Program.

Author: Mauskopf, Josephine A., Tolson, Jerry M., Simpson, Kit N., Pham, Sissi V., Albright, James
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2000
Drug therapy, Combination, Combination drug therapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Long-term impact of highly active antiretroviral therapy on HIV-related health care costs

Article Abstract:

Highly active antiretroviral therapy (HAART) can reduce the cost of treating HIV patients even though the drugs are expensive. This occurs because patients on HAART are hospitalized less often than other HIV patients, so hospital costs are substantially less.

Author: Smith, James W., Keiser, Philip, Nassar, Naiel, Kvanli, Mary Beth, Turner, Dianna, Skiest, Daniel
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2001
Statistical Data Included, Statistics, Medical care, Cost of, Health care costs, Anti-HIV agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Economic aspects, HIV infection, HIV infections
Similar abstracts:
  • Abstracts: Combination therapy from a clinician's perspective. Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-1-infected patients
  • Abstracts: Effect of supplementation of smoking men with plain or slow release ascorbic acid on lipoprotein oxidation. Low serum folate concentrations are associated with an excess incidence of acute coronary events: The Kuopion Ischaemic Heart Disease Risk Factory Study
  • Abstracts: Elective acquaints medical students with abortion. Direct observation of community-based ambulatory encounters involving medical students
  • Abstracts: Insensitivity of rapid antigen detection methods and single blood agar plate culture for diagnosing streptococcal pharyngitis
  • Abstracts: Futility and avoidance: medical professionals in the treatment of obesity. A 33-Year-Old Woman With Morbid Obesity
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.